Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yeonjoo Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Immunotherapy, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The systemic treatment of breast cancer has evolved remarkably over the past decades. With the introduction of immune checkpoint inhibitors (ICIs), clinical outcomes for solid tumor malignancies have significantly improved. However, in breast cancer, the indication for ICIs is currently limited to triple-negative breast cancer (TNBC) only. In high-risk luminal B hormone receptor-positive (HR+) breast cancer (BC) and HER2-positive (HER2+) BC, modest efficacy of ICI and chemotherapy combinations were identified in the neoadjuvant setting. To address the unmet need, several novel immunotherapy strategies are being tested in ongoing clinical trials as summarized in the current review: bispecific antibodies, chimeric antigen receptor T-cell therapy (CAR-T), T-cell receptors (TCRs), tumor-infiltrating lymphocytes (TILs), tumor vaccines, and oncolytic virus therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.
ORCID-Profile: Jiayi Tan, Jin Sun Lee, Yuan Yuan
Zitieren
APA
Choi, Y., Tan, J., Lin, D., Lee, J. S., & Yuan, Y. (2025). Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083920
Vancouver
Choi Y, Tan J, Lin D, Lee JS, Yuan Y. Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083920
BibTeX
@article{Choi2025,
author = {Choi, Yeonjoo and Tan, Jiayi and Lin, David and Lee, Jin Sun and Yuan, Yuan},
title = {Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083920}
}
EUVIMED